MCL1 and breast carcinoma: Following the literature review, the current study is the first that determines the role of MITF and Mcl-1 proteins in the MFLX-induced cellular and molecular cascade underlying the drug’s cytotoxic and pro-apoptotic effect on triple-negative MDA-MB-231 breast cancer cells.